1. Bakyaita, N., G. Dorsey, A. Yeka, K. Banek, S. G. Staedke, M. R. Kamya, A. Talisuna, F. Kironde, S. Nsobya, A. Kilian, A. Reingold, P. J. Rosenthal, and F. Wabwire-Mangen. 2005. Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda. Am. J. Trop. Med. Hyg.72:573-580.
2. Centers for Disease Control and Prevention. 1993. False-positive serologic tests for human T-cell lymphotropic virus type I among blood donors following influenza vaccination, 1992. Morb. Mortal. Wkly. Rep.42:173-175.
3. Charmot, G. 1962. Malaria and hypergammaglobulinemia in Africa. Some recent data. Med. Trop.22:667-671.
4. Chattopadhya, D., S. Kumari, R. Chatterjee, and T. Verghese. 1991. Antimalarial antibody in relation to seroreactivity for HIV infection in sera from blood donors. J. Commun. Dis.23:195-198.
5. Chikwem, J. O., I. Mohammed, and T. O. Ola. 1990. Comparison of commercial kits for the detection of antibody to human immunodeficiency virus type 1 (HIV-1) in Nigeria. East Afr. Med. J.67:209-213.